6-methylthiopurine has been researched along with Experimental Mammary Neoplasms in 1 studies
6-methylthiopurine : A thiopurine that is 9H-purine substituted by a methylsulfanyl group at position 6.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nord, LD | 1 |
| Stolfi, RL | 1 |
| Alfieri, AA | 1 |
| Netto, G | 1 |
| Reuter, V | 1 |
| Sternberg, SS | 1 |
| Colofiore, JR | 1 |
| Koutcher, JA | 1 |
| Martin, DS | 1 |
1 other study available for 6-methylthiopurine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion.
Topics: 6-Aminonicotinamide; Adenosine Triphosphate; Animals; Antimetabolites, Antineoplastic; Antineoplasti | 1997 |